- Hopeful to announce green light for Phase 3 (piv
Post# of 148166
- Thursday or Friday more results from the patients injected will be announced
- Patients in the placebo arm in the Phase 2 protocol will be able to switch to leronlimab if they get worse
- 2-3 weeks for interim/full analysis possible (Phase 2); Phase 3 interim analysis with 100 patients possibly, approval if results are good.
- Planning to treat patients in Italy and England, they are waiting for FDA clearance of the Phase 3 (severe)